Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. - Wikidata - awgldk - TriplyDB

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

http://www.wikidata.org/entity/Q42281643

about

Parenteral anticoagulation in ambulatory patients with cancer Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation The cancer stem cell: evidence for its origin as an injured autoreactive T cell Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review Platelets, coagulation and fibrinolysis in breast cancer progression Anticoagulants in cancer Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR)Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis The hypercoagulable state of malignancy: pathogenesis and current debate Opportunity cost of funding drugs for rare diseases: the cost-effectiveness of eculizumab in paroxysmal nocturnal hemoglobinuria The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials Venous thromboembolism in malignant gliomas When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature.Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.Treating venous thromboembolism in patients with cancer.Cancer and Venous Thromboembolic Disease: A Review.Clinical trials on antiphospholipid syndrome: what is being done and what is needed?Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management.Predictors of venous thromboembolism in patients with advanced common solid cancers The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review.Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report.Oral anticoagulation and risk of death: a medical record linkage study.Venous thrombosis and anticoagulant therapy.Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.Venous thromboembolism in the outpatient setting Arterial and venous thrombosis in cancer patients Warfarin for refractory chronic cluster headache: a randomized pilot study.Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.Agreement of four competing guidelines on prevention of venous thromboembolism and comparison with observed physician practices: a cross-sectional study of 1,032 medical inpatients Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement.Long-term, low-intensity warfarin after idiopathic venous thromboembolism.

P2860

Q22252972-7725238A-FFD5-4A08-8244-969D109EB323 Q24194116-31E7C3F9-C80F-45A9-9B8A-A9902E3E1E1A Q24194257-47D1DCBE-2CE0-4401-8D5A-306359B609BD Q24194926-9D8935BA-0555-401A-B780-DF6A345853D1 Q24203644-2FD20541-504F-40C8-A318-4B40F7B2C8B1 Q24235785-57C2F9E6-AC7E-4840-A177-46C527C78A80 Q24236595-9F3686BD-A71F-4532-B205-E70612B6DF25 Q25256839-42DEBD0D-C438-48F5-9FD7-BB5A5347DE94 Q26741697-2871149B-CE96-43E3-9891-CA8E01316FBA Q26753853-0B49926F-B659-440B-B6F0-F908A9F4B073 Q26823716-52E9AA8C-18AB-4429-AA25-3AF4F88BFECA Q26825228-72B1DAB1-05F2-41BB-A2F8-55E93EEA4C43 Q26995284-448722D4-AB8D-4E5B-A4B2-FECD056C79B6 Q27005043-767DB5AC-9BB9-4D85-AF15-A7D96F4F39C0 Q28212265-005BCF11-B719-45CA-8068-DF32721C9FC1 Q28243221-4A3AECAC-D208-4589-9842-3CC884C9C8CE Q28296482-1902F664-81EB-484D-9A87-C838394DD803 Q30436810-D8EC52DA-E262-4459-90FA-2EE11A1513EC Q31024426-EDE27513-A765-4947-BC85-29128EB5143D Q33365781-BB872353-2C46-4389-A375-B99BE77A57BC Q33399333-2B1E7F55-F52C-484A-9FD1-54975E5EC81C Q33400564-C5B82F90-9CAB-43A4-ADBA-C302F20AC77C Q33439089-9A839A19-B663-47F4-AC4C-A363F3A60ADD Q33490045-C83EA6EF-84A9-4897-95AE-90D98E519AEC Q33561213-54D637A2-F84D-4624-AE1C-AFD13C7FAEEA Q33671179-692ADBF3-5FDD-47DF-A9C3-1697E62D0F54 Q33763866-7EEC2B22-22B1-481A-9000-94AFE31CD977 Q33810510-765E5DCE-0D4C-48F9-8320-9274066F4D32 Q33994652-DF4D91E7-2DF9-4C78-92F4-AA8675782F3D Q34019240-2E750FFB-F795-4737-82A6-120BB9D815E6 Q34210279-B97DFB25-F2CE-4992-B179-C7EA0E7C152C Q34351113-D9E11D69-D1AC-4D2A-86CE-2676C276BAC6 Q34546366-AE38B49C-6F76-417A-A8DA-AA28334D3BA7 Q34581299-ACC1A8E8-B41A-4B2B-8307-316D6BE4BBE5 Q34635182-46714C8B-63D7-422D-A1D6-712DAF423F1A Q34660438-61FD4E5D-D3CE-4630-839B-8C57D6A12206 Q34688195-12F7356A-01D1-4874-BA04-9F5AE6E70783 Q34733377-1052392C-3EA9-40FB-AB3E-FCE40C4ECDA9 Q34743419-EB88F80B-A9C6-4767-8324-E0A8C3B53E15 Q34963687-5D99E10F-CBE9-407C-A2DC-3DFC60F9BD84

P2860

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

http://www.wikidata.org/entity/Q42281643

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Double-blind randomised trial ...... ism in stage IV breast cancer.

@en

Double-blind randomised trial ...... ism in stage IV breast cancer.

@nl

type

label

Double-blind randomised trial ...... ism in stage IV breast cancer.

@en

Double-blind randomised trial ...... ism in stage IV breast cancer.

@nl

prefLabel

Double-blind randomised trial ...... ism in stage IV breast cancer.

@en

Double-blind randomised trial ...... ism in stage IV breast cancer.

@nl

P1433

Q42281643-45A89D2A-03D2-42D4-BBE7-CB75B3D76A19

P1476

Q42281643-50019F6B-BE6E-4139-B4DE-988B50ED17E4

P2093

Q42281643-14A97583-C222-41FF-BA95-6E9EE4700E3B

Q42281643-1B0410E9-F749-4B97-A9DC-819529B90F79

Q42281643-2E113917-95EF-4545-8B44-8550E86AE067

Q42281643-3C3C195F-685A-4A92-BD65-711E5DA922FF

Q42281643-56DAD8D7-8AF5-46D9-B860-6F90642EDD4C

Q42281643-6C37D87D-B1D0-4E7D-9F97-89A5DA5280CD

Q42281643-7E9A6469-6923-42B1-8646-0A7402B11DC2

Q42281643-805C9120-383C-422C-9A83-4DADD40BDEC8

Q42281643-8775DC19-98C0-4D6D-9CAF-C4F94FC596A8

P304

Q42281643-1A130F79-15B5-4827-9A5F-E136B3288B4D

P31

Q42281643-312CDB79-51F7-483D-AA04-1F9ABABF8FEC

P356

Q42281643-54DE45AC-D0BF-4ECE-BA1D-F36C3D9BE0C2

P407

Q42281643-21F5C317-DFFA-478F-89A2-A7DEA780D5D5

P433

Q42281643-830289ED-3141-41EC-BB08-1FCBE57099C8

P478

Q42281643-343B799B-A5A8-419D-BF0A-DFA36DB5E782

P50

Q42281643-A78F923F-E963-4E03-83A8-1EF95205473E

P577

Q42281643-15EAC11F-B389-4AE1-89F3-3BAB7CFC3A19

P698

Q42281643-314DB111-E0CB-4C8C-9969-7F50E8836794

P921

Q42281643-F2C85FEA-C528-4797-A5A7-C23BF63B32B8

P356

S0140-6736(94)90008-6

P1433

P1476

Double-blind randomised trial ...... ism in stage IV breast cancer.

@en

P2093

A Arnold

http://www.w3.org/2001/XMLSchema#string

D Stewart

http://www.w3.org/2001/XMLSchema#string

D Warr

http://www.w3.org/2001/XMLSchema#string

J Hirsh

http://www.w3.org/2001/XMLSchema#string

K I Pritchard

http://www.w3.org/2001/XMLSchema#string

M Gent

http://www.w3.org/2001/XMLSchema#string

M Levine

http://www.w3.org/2001/XMLSchema#string

M Samosh

http://www.w3.org/2001/XMLSchema#string

V Bramwell

http://www.w3.org/2001/XMLSchema#string

P304

886-889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(94)90008-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

8902

http://www.w3.org/2001/XMLSchema#string

P478

343

http://www.w3.org/2001/XMLSchema#string

P50

P577

1994-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7908358

http://www.w3.org/2001/XMLSchema#string

P921

thromboembolism